Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Iversen

Showing results (101-110 of 226) with videos related to

Pageof 23
Sort By:
JAMA Dermatology|May 9, 2019
Psoriasis and Risk of Mental Disorders in DenmarkMichelle Z Leisner, Jette L Riis, Sara Schwartz, et al.
Acta Dermato-Venereologica|August 28, 2019
The MicroRNA Expression Profile Differs Between Erythrodermic Mycosis Fungoides and Sézary SyndromeAnne Hald Rittig, Lise M Lindahl, Claus Johansen, et al.
Archives of Dermatological Research|September 17, 2004
1alpha,25(OH)(2)D(3) regulates NF-kappaB DNA binding activity in cultured normal human keratinocytes through an increase in IkappaBalpha expressionJette L Riis, Claus Johansen, Borbala Gesser, et al.
International Journal of Radiation Oncology, Biology, Physics|April 13, 2015
Low-dose (10-Gy) total skin electron beam therapy for cutaneous T-cell lymphoma: an open clinical study and pooled data analysisMaria R Kamstrup, Robert Gniadecki, Lars Iversen, et al.
Frontiers in Immunology|February 24, 2023
Heat shock protein 90 inhibitor RGRN-305 potently attenuates skin inflammationHakim Ben Abdallah, Sabine Seeler, Anne Bregnhøj, et al.
Clinical and Experimental Rheumatology|September 8, 2020
HLA-B*27 is significantly enriched in Nordic patients with psoriatic arthritis mutilansPernilla Nikamo, Bjorn Gudbjornsson, Leena Laasonen, et al.
The Journal of Allergy and Clinical Immunology|October 18, 2019
IκBζ is a key player in the antipsoriatic effects of secukinumabTrine Bertelsen, Christine Ljungberg, Thomas Litman, et al.
Dermatologic Therapy|August 21, 2021
Effectiveness of brodalumab after previous treatment failure of interleukin-17A inhibitors in patients with psoriasisNikolai Loft, Anne Bregnhøj, Simon Fage, et al.
The Journal of Investigative Dermatology|November 7, 2008
Reduced oxazolone-induced skin inflammation in MAPKAP kinase 2 knockout miceAnne T Funding, Claus Johansen, Matthias Gaestel, et al.
BMJ Open|November 13, 2016
Hospital-diagnosed atopic dermatitis and long-term risk of myocardial infarction: a population-based follow-up studyJette Lindorff Riis, Christian Vestergaard, Kasper Fjellhaugen Hjuler, et al.
Pageof 23

Showing results (101-110 of 226) with videos related to

Sort By:
Pageof 23
JAMA Dermatology|May 9, 2019
Psoriasis and Risk of Mental Disorders in DenmarkMichelle Z Leisner, Jette L Riis, Sara Schwartz, et al.
Acta Dermato-Venereologica|August 28, 2019
The MicroRNA Expression Profile Differs Between Erythrodermic Mycosis Fungoides and Sézary SyndromeAnne Hald Rittig, Lise M Lindahl, Claus Johansen, et al.
Archives of Dermatological Research|September 17, 2004
1alpha,25(OH)(2)D(3) regulates NF-kappaB DNA binding activity in cultured normal human keratinocytes through an increase in IkappaBalpha expressionJette L Riis, Claus Johansen, Borbala Gesser, et al.
International Journal of Radiation Oncology, Biology, Physics|April 13, 2015
Low-dose (10-Gy) total skin electron beam therapy for cutaneous T-cell lymphoma: an open clinical study and pooled data analysisMaria R Kamstrup, Robert Gniadecki, Lars Iversen, et al.
Frontiers in Immunology|February 24, 2023
Heat shock protein 90 inhibitor RGRN-305 potently attenuates skin inflammationHakim Ben Abdallah, Sabine Seeler, Anne Bregnhøj, et al.
Clinical and Experimental Rheumatology|September 8, 2020
HLA-B*27 is significantly enriched in Nordic patients with psoriatic arthritis mutilansPernilla Nikamo, Bjorn Gudbjornsson, Leena Laasonen, et al.
The Journal of Allergy and Clinical Immunology|October 18, 2019
IκBζ is a key player in the antipsoriatic effects of secukinumabTrine Bertelsen, Christine Ljungberg, Thomas Litman, et al.
Dermatologic Therapy|August 21, 2021
Effectiveness of brodalumab after previous treatment failure of interleukin-17A inhibitors in patients with psoriasisNikolai Loft, Anne Bregnhøj, Simon Fage, et al.
The Journal of Investigative Dermatology|November 7, 2008
Reduced oxazolone-induced skin inflammation in MAPKAP kinase 2 knockout miceAnne T Funding, Claus Johansen, Matthias Gaestel, et al.
BMJ Open|November 13, 2016
Hospital-diagnosed atopic dermatitis and long-term risk of myocardial infarction: a population-based follow-up studyJette Lindorff Riis, Christian Vestergaard, Kasper Fjellhaugen Hjuler, et al.
Pageof 23